Laboratory Medicine and Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Lung 90%
3. Liver Transplantation 70%
4. Renal Cell Carcinoma 69%
5. Mesenchymal Stem Cells 65%
6. Adenocarcinoma of Lung 47%
7. Biopsy 45%
8. Breast Neoplasms 42%
9. Recurrence 41%
10. Transplants 39%
11. Lasers 38%
12. Polyps 35%
13. Thyroid Nuclear Factor 1 33%
14. Trastuzumab 33%
15. Hepatitis C 33%
16. Tissue Donors 32%
17. Allografts 32%
18. Staining and Labeling 31%
19. Kidney 31%
20. Salvage Therapy 30%
21. Immunohistochemistry 30%
22. Cell- and Tissue-Based Therapy 30%
23. Therapeutics 29%
24. Eosinophilic Esophagitis 29%
25. Proteins 28%
26. Adenoma 26%
27. Adenocarcinoma 26%
28. Survival 25%
29. Stem Cells 25%
30. Squamous Cell Carcinoma 24%
31. Liver 24%
32. Protein Kinase C 24%
33. Messenger RNA 24%
34. Prostatic Neoplasms 23%
35. Lobular Carcinoma 23%
36. Narrow Band Imaging 23%
37. Carcinoma 23%
38. Hepacivirus 23%
39. Genes 23%
40. Radiotherapy 23%
41. Endoscopy 22%
42. Barrett Esophagus 22%
43. Malignant Mesothelioma 22%
44. Transplant Recipients 21%
45. Neoplasm Metastasis 21%
46. Hematopoietic Stem Cells 21%
47. Extracellular Vesicles 21%
48. Alveolar Epithelial Cells 20%
49. Ductal Carcinoma 20%
50. Lung Neoplasms 20%
51. Neuroendocrine Tumors 19%
52. Biomarkers 18%
53. Colonoscopy 18%
54. Pathologists 18%
55. Infections 17%
56. Protein Precursors 17%
57. Safety 17%
58. Cell Biology 16%
59. plerixafor octahydrochloride 16%
60. Amyloid 16%
61. Catenins 16%
62. Feasibility Studies 16%
63. Fibrosis 16%
64. PKC-3 protein 16%
65. Growth 15%
66. Bronchiolitis Obliterans 15%
67. Large Cell Carcinoma 15%
68. Lung Diseases 15%
69. Acinar Cell Carcinoma 15%
70. TOR Serine-Threonine Kinases 15%
71. Phenotype 15%
72. Pathology 14%
73. Respiratory Mucosa 14%
74. Blood Cells 14%
75. Sirolimus 14%
76. Drug Therapy 14%
77. Disease-Free Survival 14%
78. T-Lymphocytes 14%
79. Metaplasia 14%
80. Pancreatitis 14%
81. human ERBB2 protein 13%
82. Solitary Pulmonary Nodule 13%
83. Interstitial Lung Diseases 13%
84. Histology 13%
85. IgA receptor 13%
86. Graft Survival 13%
87. Lung Transplantation 13%
88. Surface-Active Agents 13%
89. Inflammation 13%
90. Cathepsin B 13%
91. Langerhans Cell Histiocytosis 13%
92. Giant Cell Arteritis 13%
93. Breast 13%
94. Tomography 13%
95. Sclerosing Cholangitis 13%
96. Leiomyoma 13%
97. Hepatitis 13%
98. Oncogenes 13%
99. Platelet Count 13%